SABS
SAB Biotherapeutics·NASDAQ
--
--(--)
--
--(--)
SABS Filings
Filing Date
Form Description
Form Type
2026-03-31
Form S-8 - Securities to be offered to employees in employee benefit plans
Ownership
2026-03-31 · Ownership
Form S-8 - Securities to be offered to employees in employee benefit plans
2026-03-25
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-03-25 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-03-23
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-03-23 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-03-19
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-03-19 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-03-19
Form 8-K - Current report
Key Events
2026-03-19 · Key Events
Form 8-K - Current report
2026-03-17
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-03-17 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-03-11
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-03-11 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-03-10
Form 8-K - Current report
Key Events
2026-03-10 · Key Events
Form 8-K - Current report
2026-03-09
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Financials
2026-03-09 · Financials
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026-02-17
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026-02-17 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
